Trial Profile
A Phase II Open-Label Multi-Center Trial of Memantine (Namenda) Treatment of Pathological Gambling [gambling].
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2019
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Gambling
- Focus Therapeutic Use
- 23 Feb 2012 Actual patients number is 29 as reported by ClinicalTrials.gov.
- 23 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Apr 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.